OMEGA-3 POLYUNSATURATED FATTY ACIDS IN ATRIAL FIBRILLATION PREVENTION AFTER SURGICAL MYOCARDIAL REVASCULARIZATION
https://doi.org/10.20996/1819-6446-2008-4-3-26-30
Abstract
Aim. To estimate an efficacy of therapy with ω-3 polyunsaturated fatty acids (PUFA) in patients with ischemic heart disease (IHD) before and after coronary artery bypass graft (CABG).
Material and methods. 189 patients (125 men, 64 women; aged 64,2±9,4 y.o.) with IHD having indications to CABG were enrolled in the study. Patients of the first group (control) had standard pre- and postoperative treatment. Patients of the second group received ω-3 PUFA (ОМАCОR, Solvay Pharma) 2 g/daily in addition to standard therapy. Both groups were similar in clinical characteristics. ω-3 PUFA therapy started 7±4 day before CABG, renewed in early postoperative period (24-36 hours after surgery) and lasted next 14 days. Efficacy of the therapy was estimated by atrial fibrillation frequency in postoperative period and time before hospital discharge after CABG. An automatic complex for transesophageal electrophysiological cardiac examination was used for the estimation of atrial conduction before and after CABG.
Results. Omacor therapy in patients with ICD before CABG and in the early postoperative period reduces atrial fibrillation risk. It results in reduction of hemodynamic disorders and time before hospital discharge. Conclusion. Omacor therapy is safe and can be recommended to all patients going through CABG.
About the Authors
A. V. Panov
V.A. Almazov Federal Heart, Blood and Endocrinology Centre of Rosmedtechnology, Saint-Petersburg
Russian Federation
Russian Federation
B. A. Tatarskiy
V.A. Almazov Federal Heart, Blood and Endocrinology Centre of Rosmedtechnology, Saint-Petersburg
Russian Federation
Russian Federation
M. L. Gordeev
V.A. Almazov Federal Heart, Blood and Endocrinology Centre of Rosmedtechnology, Saint-Petersburg
Russian Federation
Russian Federation
R. I. Nilk
V.A. Almazov Federal Heart, Blood and Endocrinology Centre of Rosmedtechnology, Saint-Petersburg
Russian Federation
Russian Federation
References
1. Eagle K.A., Guyton R.A., Davidoff R. et al. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). Circulation 2004;110(14):e340- 437.
2. Ommen S., Odell J.A., Stanton M.S. Atrial arrhytmias after cardiothoracic surgery. N Engl J Med 1997; 336(20):1429-34.
3. Bang H.O., Dyerberg J., Sinclair H.M. The composition of the Eskimo food in Northwestern Greenland. Am J Clin Nutr 1980;33(12):2657- 66.
4. Marchioli R., Barzi F., Bomba E. et al. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Circulation 2002; 105(16):1897-903.
5. Harris W.S., Reid K.J., Sands S.A., Spertus J.A. Blood omega-3 and trans fatty acids in middle-aged acute coronary syndrome patients. Am J Cardiol 2007;99(2):154-8.
6. Yokoyama M., Origasa H., Matsuzaki M. et al. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet 2007;369(9567):1090-8.
7. Belperio J.A., Keane M.P., Arenberg D.A. et al. CXC chemokines in angiogenesis. J Leukoc Biol 2000;68(1):1-8.
8. Cal L., Bianconi L., Colivicchi F. et al. N-3 Fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a randomized, controlled trial. J Am Coll Cardiol 2005;45(10):1723-8.
9. Татарский Б.А. Использование ω-3 полиненасыщенных жирных кислот для профилактики фибрилляции предсердий после опе- рации коронарного шунтирования. Кардиоваск тер профилакт 2007;(2):52-9.
10. Kalman J.M., Munawar M., Howes L.G. et al. Atrial fibrillation after coronary artery bypass grafting is associated with sympathetic activation. Ann Thorac Surg 1995;60(6):1709-15.
11. Hogue C.W.Jr., Hyder M.L. Atrial fibrillation after cardiac operation: risks, mechanisms, and treatment. Ann Thorac Surg 2000;69(1):300- 6.
12. Aranki S.F., Shaw D.P., Adams D.H. et al. Predictors of atrial fibrillation after coronary artery surgery. Current trends and impact on hospital resources. Circulation 1996;94(3):390-7.
13. Asher C.R., Miller D.P., Grimm R.A. Analysis of risk factors for development of atrial fibrillation early after cardiac valvular surgery. Am J Cardiol 1998;82(7):892-5.
14. Hassaguerre M., Jas P., Shah D.C. et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998;339(10):659-66.
15. Demaison L., Blet J., Sergiel J.P. et al. Effect of dietary polyunsaturated fatty acids on contractile function of hearts isolated from sedentary and trained rats. Reprod Nutr Dev 2000;40(2):113-25.
16. Pepe S., McLennan P.L. Cardiac membrane fatty acid composition modulates myocardial oxygen consumption and postischemic recovery of contractile function. Circulation 2002; 105(19): 2303–2308.
Review
For citations:
Panov A.V., Tatarskiy B.A., Gordeev M.L., Nilk R.I. OMEGA-3 POLYUNSATURATED FATTY ACIDS IN ATRIAL FIBRILLATION PREVENTION AFTER SURGICAL MYOCARDIAL REVASCULARIZATION. Rational Pharmacotherapy in Cardiology. 2008;4(3):26-30. (In Russ.) https://doi.org/10.20996/1819-6446-2008-4-3-26-30
Views:
620
Email this article 